Riskpilot← Back to searchSign inGet full accessTremeda AB
ABActiveOrg 5591105902Dalagatan 73General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2024
SEK 1,1M
+39% vs 2023
EBITDA margin
52.7%
+382% vs 2023
Equity ratio
60.3%
Financial strength
Net profit 2024
SEK 448K
+382% vs 2023
| Revenue | SEK 1,1M | +39% |
| EBITDA | SEK 569K | +382% |
| Net profit | SEK 448K | +382% |
| Total assets | SEK 980K | +149% |
| Equity | SEK 591K | +313% |
| Employees | 0 | — |
Legal name
Tremeda AB
Org number
5591105902
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 maj 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom hälso- och sjukvård och närliggande områden. Investeringar i noterade och onoterade bolag samt värdepapper.
Address
Dalagatan 73
Email
ivar@tremeda.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 137 | 560 | 792 | 779 | 1 080 |
| Staff expenses | — | — | −574 | −524 | −475 |
| EBITDA | 1 051 | −21 | 171 | 118 | 569 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 1 051 | −21 | 171 | 118 | 569 |
| Net financials | −3 | 239 | 1 | −0 | −3 |
| Profit before tax | 798 | −242 | 239 | 118 | 567 |
| Tax | −172 | −0 | — | −25 | −119 |
| Net profit | 626 | −242 | 239 | 93 | 448 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 467 | 537 | 460 | 394 | 980 |
| Equity | 676 | 48 | 287 | 143 | 591 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 542 | 258 | 9 | 20 | 158 |
| Total debt | 542 | 258 | 9 | 20 | 158 |
EBITDA margin
52.7%
This company
15.8%
Market median
+234% vs market
20202024
Equity ratio
60.3%
This company
38.2%
Market median
+58% vs market
20202024
Return on equity
75.8%
This company
18.4%
Market median
+312% vs market
20202024
Net profit margin
41.5%
This company
8.1%
Market median
+412% vs market
20202024
Asset turnover
1.10×
This company
1.12×
Market median
+2% vs market
20202024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tremeda AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Ivar Gustav Dimberg | Board of Directors | 0 companies |
| Leonard Gustav Hinnerud | Deputy Board Member | 0 companies |